Piperacillin and Tazobactam for injection: Particulate
Last updated
Summary
Product
Piperacillin and Tazobactam for injection
Issue
Health products - Product quality
What to do
See instructions below.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| Teligent Canada | Piperacillin and Tazobactam for injection 4.5g | DIN 02401339 | Powder for solution | Piperacillin Sodium 4g, Tazobactam Sodium 0.5g | 305757. 305756 |
| Teligent Canada | Piperacillin and Tazobactam for injection 3.375g | DIN 02401320 | Powder for solution | Piperacillin Sodium 3g, Tazobactam Sodium 0.375 g | 305664, 305665 |
| Teligent Canada | Piperacillin and Tazobactam for injection 2.25g | DIN 02401312 | Powder for solution | Piperacillin Sodium 2g, Tazobactam Sodium 0.25g | 305666, 305718 |
Issue
Visible particles observed in vials following reconstitution
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Healthcare Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
|
Teligent Canada Inc. 5995 Avebury Road, Suite 804, Mississauga, Ontario L5R 3P9 |
Published by
Health Canada
Audience
General public
Health professionals
Hospitals
Recall class
Type I
Identification number
RA-63827
Get notified
Receive emails about new and updated recall and safety alerts.